Attached files

file filename
10-K - 10-K - AMAG PHARMACEUTICALS, INC.a2223053z10-k.htm
EX-32.1 - EX-32.1 - AMAG PHARMACEUTICALS, INC.a2223053zex-32_1.htm
EX-23.1 - EX-23.1 - AMAG PHARMACEUTICALS, INC.a2223053zex-23_1.htm
EX-31.1 - EX-31.1 - AMAG PHARMACEUTICALS, INC.a2223053zex-31_1.htm
EX-10.6 - EX-10.6 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_6.htm
EX-31.2 - EX-31.2 - AMAG PHARMACEUTICALS, INC.a2223053zex-31_2.htm
EX-10.19 - EX-10.19 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_19.htm
EX-10.31 - EX-10.31 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_31.htm
EX-10.32 - EX-10.32 - AMAG PHARMACEUTICALS, INC.a2223053zex-10_32.htm
EXCEL - IDEA: XBRL DOCUMENT - AMAG PHARMACEUTICALS, INC.Financial_Report.xls
EX-32.2 - EX-32.2 - AMAG PHARMACEUTICALS, INC.a2223053zex-32_2.htm

Exhibit 21.1

 

AMAG Pharmaceuticals, Inc.

 

Subsidiaries of the registrant

 

AMAG Pharmaceuticals Canada Corporation, a Nova Scotia unlimited liability company

 

AMAG Europe Limited, a UK private limited company

 

AMAG Securities Corporation, a Massachusetts corporation

 

Lumara Health Inc., a Delaware corporation

 

FP1096, Inc., a Pennsylvania corporation

 

Lumara Health IP Ltd., a Delaware corporation

 

Drugtech Sárl, a Swiss company

 

Lumara Health Services Ltd., a Missouri corporation

 

K-V Pharmaceuticals Company Limited, a UK private limited company

 

K-V Discovery Solutions, Inc., a New York corporation